NCT03554408View on ClinicalTrials.gov

First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

February 4, 2021

Study Completion Date

February 4, 2021

Conditions
Human Immunodeficiency Virus
Interventions
DRUG

10-1074-LS

Subcutaneous injection of 10-1074-LS

DRUG

10-1074-LS

Intravenous infusion of 10-1074-LS

DRUG

3BNC117-LS

Subcutaneous injection of 3BNC117-LS

DRUG

3BNC117-LS

Intravenous infusion of 3BNC117-LS

Trial Locations (1)

10065

The Rockefeller University, New York

All Listed Sponsors
lead

Rockefeller University

OTHER

NCT03554408 - First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS | Biotech Hunter | Biotech Hunter